The Future of Bladder Cancer

January 23, 2014
Arjun Balar, MD

Arjun Balar, MD, assistant professor of medicine, Division of Hematology & Oncology, New York University Cancer Institute, NYU Langone Medical Center, discusses the future of bladder cancer.

Arjun Balar, MD, assistant professor of medicine, Division of Hematology & Oncology, New York University Cancer Institute, NYU Langone Medical Center, discusses the future of bladder cancer.

Clinical Pearls:

  • Within the next 10 years, physicians will have hopefully moved away from using chemotherapy to treat patients with bladder cancer
  • Physicians need to refine their understanding of the genetic makeup of bladder cancer in order identify validating predictive biomarkers
  • Hopefully in the future, physicians will be able to biopsy a tumor in real time, identify actionable alterations in the patient’s tumor, and select a particular therapy based on the findings